These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 15271902)
1. The major subunit of the toxin-coregulated pilus TcpA induces mucosal and systemic immunoglobulin A immune responses in patients with cholera caused by Vibrio cholerae O1 and O139. Asaduzzaman M; Ryan ET; John M; Hang L; Khan AI; Faruque AS; Taylor RK; Calderwood SB; Qadri F Infect Immun; 2004 Aug; 72(8):4448-54. PubMed ID: 15271902 [TBL] [Abstract][Full Text] [Related]
2. Transcutaneous immunization with toxin-coregulated pilin A induces protective immunity against Vibrio cholerae O1 El Tor challenge in mice. Rollenhagen JE; Kalsy A; Cerda F; John M; Harris JB; Larocque RC; Qadri F; Calderwood SB; Taylor RK; Ryan ET Infect Immun; 2006 Oct; 74(10):5834-9. PubMed ID: 16988262 [TBL] [Abstract][Full Text] [Related]
3. The Live Attenuated Cholera Vaccine CVD 103-HgR Primes Responses to the Toxin-Coregulated Pilus Antigen TcpA in Subjects Challenged with Wild-Type Vibrio cholerae. Mayo-Smith LM; Simon JK; Chen WH; Haney D; Lock M; Lyon CE; Calderwood SB; Kirkpatrick BD; Cohen M; Levine MM; Gurwith M; Harris JB Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27847368 [TBL] [Abstract][Full Text] [Related]
4. Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge. Kundu J; Mazumder R; Srivastava R; Srivastava BS FEMS Immunol Med Microbiol; 2009 Jul; 56(2):179-84. PubMed ID: 19453752 [TBL] [Abstract][Full Text] [Related]
5. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses. Shamsuzzaman S; Ahmed T; Mannoor K; Begum YA; Bardhan PK; Sack RB; Sack DA; Svennerholm AM; Holmgren J; Qadri F Vaccine; 2009 Feb; 27(9):1386-92. PubMed ID: 19146897 [TBL] [Abstract][Full Text] [Related]
6. Plasma and Mucosal Immunoglobulin M, Immunoglobulin A, and Immunoglobulin G Responses to the Vibrio cholerae O1 Protein Immunome in Adults With Cholera in Bangladesh. Charles RC; Nakajima R; Liang L; Jasinskas A; Berger A; Leung DT; Kelly M; Xu P; Kovác P; Giffen SR; Harbison JD; Chowdhury F; Khan AI; Calderwood SB; Bhuiyan TR; Harris JB; Felgner PL; Qadri F; Ryan ET J Infect Dis; 2017 Jul; 216(1):125-134. PubMed ID: 28535267 [TBL] [Abstract][Full Text] [Related]
7. A comparison of clinical and immunologic features in children and older patients hospitalized with severe cholera in Bangladesh. Chowdhury F; Khan AI; Harris JB; LaRocque RC; Chowdhury MI; Ryan ET; Faruque AS; Calderwood SB; Qadri F Pediatr Infect Dis J; 2008 Nov; 27(11):986-92. PubMed ID: 18833030 [TBL] [Abstract][Full Text] [Related]
8. A Vibrio cholerae classical TcpA amino acid sequence induces protective antibody that binds an area hypothesized to be important for toxin-coregulated pilus structure. Taylor RK; Kirn TJ; Meeks MD; Wade TK; Wade WF Infect Immun; 2004 Oct; 72(10):6050-60. PubMed ID: 15385509 [TBL] [Abstract][Full Text] [Related]
10. TcpF is a soluble colonization factor and protective antigen secreted by El Tor and classical O1 and O139 Vibrio cholerae serogroups. Kirn TJ; Taylor RK Infect Immun; 2005 Aug; 73(8):4461-70. PubMed ID: 16040956 [TBL] [Abstract][Full Text] [Related]
11. Comparison of immune responses to the O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 in Bangladeshi adult patients with cholera. Johnson RA; Uddin T; Aktar A; Mohasin M; Alam MM; Chowdhury F; Harris JB; LaRocque RC; Bufano MK; Yu Y; Wu-Freeman Y; Leung DT; Sarracino D; Krastins B; Charles RC; Xu P; Kovác P; Calderwood SB; Qadri F; Ryan ET Clin Vaccine Immunol; 2012 Nov; 19(11):1712-21. PubMed ID: 22993410 [TBL] [Abstract][Full Text] [Related]
12. The toxin-coregulated pilus is a colonization factor and protective antigen of Vibrio cholerae El Tor. Voss E; Manning PA; Attridge SR Microb Pathog; 1996 Mar; 20(3):141-53. PubMed ID: 8965675 [TBL] [Abstract][Full Text] [Related]
13. Defining Polysaccharide-Specific Antibody Targets against Vibrio cholerae O139 in Humans following O139 Cholera and following Vaccination with a Commercial Bivalent Oral Cholera Vaccine, and Evaluation of Conjugate Vaccines Targeting O139. Kamruzzaman M; Kelly M; Charles RC; Harris JB; Calderwood SB; Akter A; Biswas R; Kaisar MH; Bhuiyan TR; Ivers LC; Ternier R; Jerome JG; Pfister HB; Lu X; Soliman SE; Ruttens B; Saksena R; Mečárová J; Čížová A; Qadri F; Bystrický S; Kováč P; Xu P; Ryan ET mSphere; 2021 Aug; 6(4):e0011421. PubMed ID: 34232076 [TBL] [Abstract][Full Text] [Related]
14. Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh. Saha D; LaRocque RC; Khan AI; Harris JB; Begum YA; Akramuzzaman SM; Faruque AS; Ryan ET; Qadri F; Calderwood SB J Infect Dis; 2004 Jun; 189(12):2318-22. PubMed ID: 15181581 [TBL] [Abstract][Full Text] [Related]
15. Evolutionary and functional analyses of variants of the toxin-coregulated pilus protein TcpA from toxigenic Vibrio cholerae non-O1/non-O139 serogroup isolates. Boyd EF; Waldor MK Microbiology (Reading); 2002 Jun; 148(Pt 6):1655-1666. PubMed ID: 12055286 [TBL] [Abstract][Full Text] [Related]
16. Induction of systemic, mucosal and memory antibody responses targeting Vibrio cholerae O1 O-specific polysaccharide (OSP) in adults following oral vaccination with an oral killed whole cell cholera vaccine in Bangladesh. Akter A; Dash P; Aktar A; Jahan SR; Afrin S; Basher SR; Hakim A; Lisa AK; Chowdhury F; Khan AI; Xu P; Charles RC; Kelly M; Kováč P; Harris JB; Bhuiyan TR; Calderwood SB; Ryan ET; Qadri F PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007634. PubMed ID: 31369553 [TBL] [Abstract][Full Text] [Related]
17. Immunizing adult female mice with a TcpA-A2-CTB chimera provides a high level of protection for their pups in the infant mouse model of cholera. Price GA; Holmes RK PLoS Negl Trop Dis; 2014 Dec; 8(12):e3356. PubMed ID: 25474636 [TBL] [Abstract][Full Text] [Related]
18. Mucosal immunologic responses in cholera patients in Bangladesh. Uddin T; Harris JB; Bhuiyan TR; Shirin T; Uddin MI; Khan AI; Chowdhury F; LaRocque RC; Alam NH; Ryan ET; Calderwood SB; Qadri F Clin Vaccine Immunol; 2011 Mar; 18(3):506-12. PubMed ID: 21248157 [TBL] [Abstract][Full Text] [Related]
19. Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers. Islam K; Hossain M; Kelly M; Mayo Smith LM; Charles RC; Bhuiyan TR; Kováč P; Xu P; LaRocque RC; Calderwood SB; Simon JK; Chen WH; Haney D; Lock M; Lyon CE; Kirkpatrick BD; Cohen M; Levine MM; Gurwith M; Harris JB; Qadri F; Ryan ET PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006376. PubMed ID: 29624592 [TBL] [Abstract][Full Text] [Related]
20. Comparison of O-specific polysaccharide responses in patients following infection with Kaisar MH; Kelly M; Kamruzzaman M; Bhuiyan TR; Chowdhury F; Khan AI; LaRocque RC; Calderwood SB; Harris JB; Charles RC; Čížová A; Mečárová J; Korcová J; Bystrický S; Kováč P; Xu P; Qadri F; Ryan ET mSphere; 2023 Oct; 8(5):e0025523. PubMed ID: 37646517 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]